Meta-analysis of Lanqin Oral Liquid Alone or Combined with Western Medicine in Treating Hand,Foot and Mouth Disease in Children
Author:
Affiliation:
Fund Project:
摘要
|
图/表
|
访问统计
|
参考文献
|
相似文献
|
引证文献
|
资源附件
|
文章评论
摘要:
目的:评价蓝芩口服液联合西药治疗小儿手足口病的临床疗效和安全性。方法:检索国家知识基础设施数据库(CNKI)、中国学术期刊数据库(CSPD)及中文科技期刊数据库(CCD)、SinMed、PubMed、Web of science、EMbase、Cochrane Library中的蓝芩口服液或联合西药治疗小儿手足口病的随机对照试验。对最终纳入的文献进行Meta分析。结果:共纳入45篇文献,总样本量为5 374例。结果显示高质量的研究占22.2%),中等质量的研究占62.2%,低质量的研究占15.6%,整体质量不高。Meta分析结果显示蓝芩口服液联合利巴韦林的效果优于利巴韦林(RR=1.22,95%CI为1.19~1.26,P<0.05),蓝芩口服液总有效率优于利巴韦林(RR=1.15,95%CI为1.05~1.26,P<0.05),安全性差异不大(RR=1.20,95%CI为0.84~1.70,P>0.05)。结论:蓝芩口服液或联合西药小儿手足口病的临床疗效较好,但由于纳入文献数量少,还需要寻找更多的证据。
Abstract:
To evaluate the clinical efficacy and safety of Lanqin oral liquid alone or combined with Western medicine in the treatment of hand,foot and mouth disease in children.Methods:China National Knowledge Infrastructure(CNKI),China Science Periodical Database(CSPD),Chinese Citation Database(CCD),SinMed,PubMed,Web of Science,EMbase,and Cochrane Library were searched for the randomized controlled trials of Lanqin oral liquid alone or combined with Western medicine in the treatment of hand,foot and mouth disease in children.A meta-analysis was performed on the final included articles.Results:A total of 45 articles were included,involving 5 374 cases.The studies of high quality,medium quality,and low quality accounted for 22.2%,62.2%,and 15.6%,respectively,which indicated overall low quality.The results of meta-analysis showed that Lanqin oral liquid combined with ribavirin outperformed ribavirin(RR=1.22,95%CI of 1.19 to 1.26,P<0.05),and the total response rate of Lanqin oral liquid was higher than that of ribavirin(RR=1.15,95%CI of 1.05 to 1.26,P<0.05).There was no significant difference in the safety(RR=1.20,95%CI of 0.84 to 1.70,P>0.05).Conclusion:Lanqin oral liquid alone or combined with Western medicine has a good clinical effect on hand,foot and mouth disease in children.However,due to the small number of included articles,more evidence remains to be explored.